Oxford Immunotec Global Limited
Manufacture of pharmaceutical preparations · Abingdon
ActiveUnited KingdomIncorporated 2013Private Limited Company
Financial position
Accounts to 2023-12-31 · GBP · company scope
Net assets
£144,070
Cash
£706
Turnover
—
Profit / loss
—
Current assets
£86,183
Creditors < 1 year
—
Equity
£144,070
Average employees
0
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2023-12-31GBP · company | 2023-01-01GBP · company |
|---|---|---|
| Balance sheet | ||
| Net assets | £144,070 | £206,108 |
| Equity | £144,070 | £206,108 |
| Assets | ||
| Fixed assets | £57,915 | £119,109 |
| Current assets | £86,183 | £87,027 |
| Cash at bank | £706 | £746 |
| Debtors | £85,477 | £86,281 |
| Liabilities | ||
| Net current assets | £86,183 | £87,027 |
| Assets less current liabilities | £144,098 | £206,136 |
| Profit & loss | ||
| Operating profit | −£2,284 | −£199 |
| Profit before tax | −£62,036 | £436 |
| People | ||
| Average employees | 0 | 0 |
| Source evidence | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesShow 8 satisfied / released
Fixed · created 2016-10-04 · satisfied 2018-11-07
—
SatisfiedFixed · created 2016-10-04 · satisfied 2018-11-07
—
SatisfiedFloating · created 2016-10-04 · satisfied 2018-11-07
—
SatisfiedFixed · created 2016-10-04 · satisfied 2018-11-07
—
SatisfiedFloating · created 2016-10-04 · satisfied 2018-11-07
—
SatisfiedFixed · created 2016-10-04 · satisfied 2018-11-07
—
SatisfiedFixed · created 2016-10-04 · satisfied 2018-11-07
—
SatisfiedFixed · created 2016-10-04 · satisfied 2018-11-07
—
Satisfied